NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today the opening of a new 280,000 square-foot Research and Development (R&D) hub in Cambridge, Mass. The new Pfizer facilities in Kendall Square bring together 1,000 colleagues from three area locations and position Pfizer in closer proximity to leading academic institutions, hospitals and patient organizations.
Pfizer Opens New State-of-the-Art Research and Development Site in Cambridge, Massachusetts | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.